- Home
- MCRB vs NEGG Comparison
MCRB vs NEGG Comparison
Compare MCRB & NEGG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- NEGG
- Stock Information
- Founded
- MCRB 2010
- NEGG 2001
- Country
- MCRB United States
- NEGG United States
- Employees
- MCRB N/A
- NEGG N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- NEGG Other Specialty Stores
- Sector
- MCRB Health Care
- NEGG Consumer Discretionary
- Exchange
- MCRB Nasdaq
- NEGG Nasdaq
- Market Cap
- MCRB 144.8M
- NEGG 122.3M
- IPO Year
- MCRB 2015
- NEGG 2010
- Fundamental
- Price
- MCRB $16.87
- NEGG $71.72
- Analyst Decision
- MCRB Hold
- NEGG
- Analyst Count
- MCRB 3
- NEGG 0
- Target Price
- MCRB $14.33
- NEGG N/A
- AVG Volume (30 Days)
- MCRB 88.5K
- NEGG 1.1M
- Earning Date
- MCRB 11-05-2025
- NEGG 12-01-2025
- Dividend Yield
- MCRB N/A
- NEGG N/A
- EPS Growth
- MCRB N/A
- NEGG N/A
- EPS
- MCRB 0.62
- NEGG N/A
- Revenue
- MCRB $351,000.00
- NEGG $1,313,127,000.00
- Revenue This Year
- MCRB N/A
- NEGG N/A
- Revenue Next Year
- MCRB N/A
- NEGG N/A
- P/E Ratio
- MCRB $26.91
- NEGG N/A
- Revenue Growth
- MCRB N/A
- NEGG N/A
- 52 Week Low
- MCRB $6.53
- NEGG $3.32
- 52 Week High
- MCRB $24.67
- NEGG $137.84
- Technical
- Relative Strength Index (RSI)
- MCRB 51.80
- NEGG 50.04
- Support Level
- MCRB $12.48
- NEGG $69.43
- Resistance Level
- MCRB $14.35
- NEGG $96.29
- Average True Range (ATR)
- MCRB 1.18
- NEGG 10.50
- MACD
- MCRB 0.22
- NEGG -0.75
- Stochastic Oscillator
- MCRB 80.50
- NEGG 31.89
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally. Geographically, it operates in United States, Canada, and Rest of World.